Clinical Trials · NCT03397537

Neoadjuvant Endocrine Therapy in Breast Cancer

CompletedPhase 2Gonadorelin (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
Guangdong Provincial People's Hospital
Enrollment
46
Start date
Sep 2012
Locations
1 site, China
Primary endpoint
ORR
View Gonadorelin compound reference